KELLEY SHAFFER: Open Payments
NPI 1538782677 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 77 payments from 18 companies in 2025. Trend: 2023 $711 · 2024 $1,295 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $199 |
| Novo Nordisk Inc | 12 | $187 |
| Lilly USA, LLC | 8 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| Biogen, Inc. | 4 | $86 |
| PFIZER INC. | 4 | $77 |
| Abbott Laboratories | 4 | $69 |
| SANOFI-AVENTIS U.S. LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Astellas Pharma US Inc | 3 | $56 |
Products named: MOUNJARO, BREZTRI, QULIPTA, ZURZUVAE, VRAYLAR, REXULTI, TZIELD, Veozah.
Industry payments across TX — which companies pay providers there.
